Science journalism · Not medical advice Regulatory window · PCAC review in 42 days

Peptide reference

5-Amino-1MQ

5-Amino-1MQ

In vitro

A small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that regulates NAD+ metabolism and adipogenesis. Not a peptide by strict definition — it is a quinolinium salt — but listed alongside peptides on the PCAC docket. In mouse models it reduced fat mass and prevented diet-induced obesity without caloric restriction. Human data: none published. The mechanism is real; the translation is unproven.

FDA status
No FDA approval. Under PCAC July 23–24 2026 review for 503A bulk substance consideration.
WADA status
Not applicable
Route
oral

Wolverine Health is building physician-supervised peptide protocols. Get early access.

Join the waitlist

No articles yet on 5-Amino-1MQ

This peptide is on the PCAC review docket but hasn't been covered in depth yet. New research coverage drops regularly — join the waitlist to be first to know.